TY  - JOUR
AU  - Decoster, Lore
AU  - Giron, Philippe
AU  - Mignon, Sacha
AU  - De Grève, Jacques
PY  - 2018
TI  - The evolving first-line treatment of advanced non-small cell lung cancer harbouring epidermal growth factor receptor mutations
JF  - Translational Lung Cancer Research; Vol 7, Supplement 2 (April 23, 2018): Translational Lung Cancer Research
Y2  - 2018
KW  - 
N2  - The current standard first-line treatment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harbouring an epidermal growth factor receptor (EGFR) mutation is a first or second-generation EGFR tyrosine kinase inhibitor (TKI) (1,2).
UR  - https://tlcr.amegroups.org/article/view/19972